GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MegaPro Biomedical Co Ltd (ROCO:6827) » Definitions » Deferred Policy Acquisition Costs

MegaPro Biomedical Co (ROCO:6827) Deferred Policy Acquisition Costs


View and export this data going back to 2021. Start your Free Trial

What is MegaPro Biomedical Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


MegaPro Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 66, Shengyi 5th Road, 10F-1, Hsinchu Science Park, Hsinchu, TWN, 31040
MegaPro Biomedical Co Ltd is a nanomedicine development company. The Company's only reportable operating segment is the Drug Application Development segment, which is engaged in the development of nano-iron oxide IOP drugs.